chrysophanic acid has been researched along with Diabetic Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, YX; Luo, J; Wang, PC; Wei, W; Yan, YM; Yang, Y; Yang, YX; Zhang, LS; Zhou, XJ | 1 |
| Guo, C; Piao, Y; Rao, X; Wang, Y; Yin, D | 1 |
2 other study(ies) available for chrysophanic acid and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Anthraquinone derivatives from Rumex plants and endophytic Aspergillus fumigatus and their effects on diabetic nephropathy.
Topics: Anthraquinones; Aspergillus fumigatus; Cell Survival; Diabetic Nephropathies; Dose-Response Relationship, Drug; Extracellular Matrix; Glycosides; Humans; Interleukin-6; Mesangial Cells; Molecular Structure; Naphthalenes; Renal Insufficiency, Chronic; Rumex; Structure-Activity Relationship | 2013 |
Chrysophanol Inhibits the Progression of Diabetic Nephropathy via Inactivation of TGF-β Pathway.
Topics: Animals; Anthraquinones; Apoptosis; Cell Cycle; Cell Proliferation; Cells, Cultured; Diabetic Nephropathies; Disease Models, Animal; Humans; Male; Mice; Mice, Inbred C57BL; Streptozocin; Transforming Growth Factor beta | 2020 |